274 related articles for article (PubMed ID: 15497779)
1. [Immunophenotyping of haematologic malignancies].
Koehorst SG; Evers H; van Buul T; de Vries F; Haanen C
Ned Tijdschr Geneeskd; 2004 Sep; 148(38):1861-5. PubMed ID: 15497779
[TBL] [Abstract][Full Text] [Related]
2. [Immunophenotyping of leukemia: overview].
Huber K; Worofka B; Kittl E; Tomasits J; Hofmann J; Bauer K
Wien Klin Wochenschr; 1994; 106(8):226-30. PubMed ID: 8023514
[TBL] [Abstract][Full Text] [Related]
3. [Clinical uses of flow cytometry in hematological oncology].
D'Ostilio A; Ginaldi L; Marini L; Di Gennaro A; De Martinis M; Quaglino D
Recenti Prog Med; 1997 Apr; 88(4):157-65. PubMed ID: 9206811
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometry and its use in the diagnosis and management of mature lymphoid malignancies.
de Tute RM
Histopathology; 2011 Jan; 58(1):90-105. PubMed ID: 21261686
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometry. Clinical and research applications in hematologic malignancies.
Huh YO; Andreeff M
Hematol Oncol Clin North Am; 1994 Aug; 8(4):703-23. PubMed ID: 7961287
[TBL] [Abstract][Full Text] [Related]
6. Quantitative identification of blood cell markers in human hematopoietic malignancies with diagnostic and prognostic significance.
Kusenda J
Neoplasma; 2008; 55(5):381-6. PubMed ID: 18665747
[TBL] [Abstract][Full Text] [Related]
7. [Flow cytometry--use in cell biology and benefits in clinical medicine].
Clausen OP; Olsen G; Tjønnfjord GE
Tidsskr Nor Laegeforen; 2000 Feb; 120(4):489-95. PubMed ID: 10833942
[TBL] [Abstract][Full Text] [Related]
8. A relational database for diagnosis of hematopoietic neoplasms using immunophenotyping by flow cytometry.
Nguyen AN; Milam JD; Johnson KA; Banez EI
Am J Clin Pathol; 2000 Jan; 113(1):95-106. PubMed ID: 10631862
[TBL] [Abstract][Full Text] [Related]
9. [Morphology and immunophenotyping in hematological malignancies].
Kawai Y; Shimizu N; Ujiie M; Takeshita E; Todoroki T; Mitsuhashi T; Watanabe K
Rinsho Byori; 2000 Aug; 48(8):694-701. PubMed ID: 11064591
[TBL] [Abstract][Full Text] [Related]
10. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
11. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia.
Wood BL; Arroz M; Barnett D; DiGiuseppe J; Greig B; Kussick SJ; Oldaker T; Shenkin M; Stone E; Wallace P
Cytometry B Clin Cytom; 2007; 72 Suppl 1():S14-22. PubMed ID: 17803189
[TBL] [Abstract][Full Text] [Related]
12. Detection of malignant haematopoietic cells in the cerebrospinal fluid by conventional cytology and flow cytometry.
Nückel H; Novotny JR; Noppeney R; Savidou I; Dührsen U
Clin Lab Haematol; 2006 Feb; 28(1):22-9. PubMed ID: 16430456
[TBL] [Abstract][Full Text] [Related]
13. OMIP-010: a new 10-color monoclonal antibody panel for polychromatic immunophenotyping of small hematopoietic cell samples.
Preijers FW; Huys E; Moshaver B
Cytometry A; 2012 Jun; 81(6):453-5. PubMed ID: 22532446
[No Abstract] [Full Text] [Related]
14. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry immunophenotyping of hematolymphoid neoplasia.
Calvo KR; McCoy CS; Stetler-Stevenson M
Methods Mol Biol; 2011; 699():295-316. PubMed ID: 21116989
[TBL] [Abstract][Full Text] [Related]
16. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometry applications in detection and classification of leukemia/lymphoma.
Widen RH
J Fla Med Assoc; 1992 Dec; 79(12):841-4. PubMed ID: 1474369
[TBL] [Abstract][Full Text] [Related]
18. [Flow cytometry: application for the diagnosis and the follow-up of hematological malignancies].
Drénou B; Fardel O; Fauchet R; Amiot L
Ann Biol Clin (Paris); 2002; 60(6):663-72. PubMed ID: 12446230
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of a germinal center immunophenotype in lymphomas by immunocytochemistry and flow cytometry.
Jack A; Barrans S; Blythe D; Rawstron A
Methods Mol Med; 2005; 115():65-91. PubMed ID: 15998963
[TBL] [Abstract][Full Text] [Related]
20. Quantitative immune phenotyping: a new dimension for the monitoring of haemopoietic malignancies.
Lavabre-Bertrand T; George F; Brunet C; Sampol J
Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):373-82. PubMed ID: 7892132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
